Cigarette smoke induces demethylation of prometastatic oncogene synuclein-γ in lung cancer cells by downregulation of DNMT3B

Oncogene

Volumn 26, Issue 40, 2007, Pages 5900-5910

  Liu, H ^a   Zhou, Y ^a   Boggs, S E ^b   Belinsky, S A ^b   Liu, J ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

Cell invasion; Cigarette smoke extract; DNA methylation; DNMT3B; Lung cancer; Synuclein g

Indexed keywords

DNA (CYTOSINE 5) METHYLTRANSFERASE; DNMT3B PROTEIN, HUMAN; GAMMA SYNUCLEIN; SNCG PROTEIN, HUMAN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL NUCLEUS; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; DOSE RESPONSE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; SMOKING; TIME; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL NUCLEUS; CPG ISLANDS; DISEASE PROGRESSION; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GAMMA-SYNUCLEIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; LUNG NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; SMOKING; TIME FACTORS;

EID: 35148873511     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210400     Document Type: Article

References (44)

1. Bachman KE, Rountree MR, Baylin SB. (2001). Dnmt3a and Dnmt3b are transcriptional repressors that exhibit unique localization properties to heterochromatin. J Biol Chem 76: 32282-32287.
2. Belinsky SA, Klinge DM, Stidley CA, Issa JP, Herman JG, March TH et al. (2003). Inhibition of DNA methylation and histone deacetylation prevents murine lung cancer. Cancer Res 63: 7089-7093. (Pubitemid 37413444)
3. Belinsky SA, Nikula KJ, Baylin SB, Issa J-P. (1996). Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer. Proc Natl Acad Sci USA 93: 4045-4050. (Pubitemid 26144243)
4. Belinsky SA. (2004). Gene-promoter hypermethylation as a biomarker in lung cancer. Nat Rev Can 4: 1-11.
5. Brueckner B, Lyko F. (2004). DNA methyltransferase inhibitors: old and new drugs for an epigenetic cancer therapy. Trends Pharmacol Sci 25: 551-554. (Pubitemid 39371143)
6. Bruening W, Giasson B, Klein-Szanto J, Lee V, Trojanowski J, Godwin A. (2000). Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 88: 2154-2163. (Pubitemid 30233219)
7. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B et al. (2001). Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression. J Natl Cancer Inst 93: 691-699. (Pubitemid 32492810)
8. Cao D, Maitra A, Saavedra JA, Klimstra DS, Adsay NV, Hruban RH. (2005). Expression of novel markers of pancreatic ductal adenocarcinoma in pancreatic nonductal neoplasms: additional evidence of different genetic pathways. Mod Pathol 1: 1-10.
9. Dodge JE, Okano M, Dick F, Tsujimoto N, Chen T, Wang S et al. (2005). Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J Biol Chem 280: 17986-17991. (Pubitemid 41389041)
10. Fujiwara K, Fujimoto N, Tabata M, Nishii K, Matsuo K, Hotta K et al. (2005). Identification of epigenetic aberrant promoter methylation in serum DNA is useful for early detection of lung cancer. Clin Cancer Res 11: 1219-1225. (Pubitemid 40175774)
11. Gius D, Cui H, Bradbury CM, Cook J, Smart DK, Zhao S et al. (2004). Distinct effects on expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. Cancer Cell 6: 361-371. (Pubitemid 39361437)
12. Guo Y, Pakneshan P, Gladu J, Slack A, Szyf M. (2002). Regulation of DNA methylation in human breast cancer. J Biol Chem 277: 41571-41579.
13. Hecht SS. (1999). Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst 91: 1194-1210. (Pubitemid 29357186)
14. Hermann A, Gowher H, Jeltsch A. (2004). Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol Life Sci 61: 2571-2587. (Pubitemid 39586518)
15. Jemal A, Thomas A, Murray T, Thun M. (2002). Cancer statistics. CA Cancer J Clin 52: 23-47.
16. Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G et al. (1997). Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing. Cancer Res 57: 759-764. (Pubitemid 27085663)
17. Lavedan C, Leroy E, Dehejia A, Buchholtz S, Dutra A, Nussbaum RL et al. (1998). Identification, localization and characterization of the human g-synuclein gene. Human Gene 103: 106-112. (Pubitemid 28398395)
18. Li Z, Sclabas GM, Peng B, Hess KR, Abbruzzese JL, Evans DB et al. (2004). Overexpression of synuclein-g in pancreatic adenocarcinoma. Cancer 101: 58-65.
19. Lin RK, Hsu HS, Cheng JW, Chen CY, Chen JT, Wang YC. (2007). Alteration of DNA methyltransferases contributes to 50CpG methylation and poor prognosis in lung cancer. Lung Cancer 55: 205-213.
20. Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C et al. (2005). Loss of epigenetic control of synuclein-gamma gene as a molecular indicator for metastasis in a wide range of human cancers. Cancer Res 65: 7635-7643. (Pubitemid 41297236)
21. Loriot A, Plaen ED, Boon T, Smet CD. (2006). Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells. J Biol Chem 281: 10118-10126. (Pubitemid 43864547)
22. Lu A, Gupta A, Li C, Ahlborn TE, Ma Y, Shi EY et al. (2001). Molecular mechanisms for aberrant expression of the human breast cancer specific gene 1 in breast cancer cells: control of transcription by DNA methylation and intronic sequences. Oncogene 20: 5173-5185. (Pubitemid 32844046)
23. Lyko F, Ramsahoye BH, Kashevsky H, Tudor M, Mastrangelo MA, Orr-Weaver TL et al. (1999). Mammalian (cytosine-5) methyltransferases cause genomic DNA methylation and lethality in Drosophila. Nat Genet 23: 363-366. (Pubitemid 29526439)
24. Mercer BA, Kolesnikova N, Sonett J, D'Armiento J. (2004). Extracellular regulated kinase/mitogen activated protein kinase is up-regulated in pulmonary emphysema and mediates matrix metalloproteinase-1 induction by cigarette smoke. J Biol Chem 279: 17690-17696. (Pubitemid 38568101)
25. Oka M, Rodi N, Graddy J, Chang LJ, Terada N. (2006). CpG sites preferentially methylated by Dnmt3a in vivo. J Biol Chem 281: 9901-9908. (Pubitemid 43864522)
26. Okano M, Bell DW, Haber DA, Li E. (1999). DNA methyltransferases Dnmt3a and Dnmt3b are essential for the de novo methylation and mammalian development. Cell 99: 247-257. (Pubitemid 29519904)
27. Pakneshan P, Szyf M, Farias-Eisner R, Rabbani SA. (2004). Reversal of the hypomethylation status of Urokinase (uPA) promoter blocks breast cancer growth and metastasis. J Biol Chem 279: 31735-31744. (Pubitemid 39037845)
28. Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG et al. (2000). Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res 60: 5954-5958.
29. Patra SK, Patra A, Zhao H, Dahiya R. (2006). DNA methyltransferase and demethylase in human prostate cancer. Molec Carcinogenesis 33: 163-171.
30. Pfeifer GP, Drahovsky D. (1986). Preferential binding of DNA methyltransferase and increased de novo methylation of deoxyionosine containing DNA. FEBS Lett 207: 75-78. (Pubitemid 17196105)
31. Pruitt K, Ulku AS, Frantz K, Rojas RJ, Muniz-Medina VM, Rangnekar VM et al. (2005). Ras-mediated loss of the proapoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. J Biol Chem 280: 23363-23370. (Pubitemid 40853250)
32. Pulling LC, Vuillemenot BR, Hutt JA, Devereux TR, Belinsky SA. (2004). Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Cancer Res 64: 3844-3848. (Pubitemid 38697294)
33. Rhee I, Bachman KE, Park BH, Jair KW, Yen RW, Schuebel KE et al. (2002). DNMT1 and DNMT3B cooperate to silence genes in human cancer cells. Nature 416: 552-556. (Pubitemid 34288859)
34. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A et al. (2003). DNMT1 is required for maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33: 61-65. (Pubitemid 36068683)
35. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA et al. (1999). The human DNA methyltransferases (DNMTs) 1, 3a, and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 27: 2291-2298. (Pubitemid 29245646)
36. Rountee MR, Bachman KE, Baylin SB. (2000). DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci. Nat Genet 25: 269-276.
37. Russo A. (2005). Differential DNA hypermethylation of critical genes mediates the stage-specific tobacco smokeinduced neoplastic progression of lung cancer. Clin Chem Lab Med 11: 2466-2470. (Pubitemid 40569441)
38. Schrump DS, Nguyen DM. (2005). Targeting the epigenome for the treatment and prevention of lung cancer. Semin Oncol 32: 488-502. (Pubitemid 41396426)
39. Suzuki M, Sunaga N, Toyppka S, Gazdar AF, Minna JD. (2004). RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res 64: 3137-3143. (Pubitemid 38581414)
40. Thompson E. (2005). Latest advances and research in lung cancer. Drug News Prespect 18: 405-411. (Pubitemid 43073875)
41. Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H et al. (2003). Stage-specific expression of breast cancer-specific gene g-synuclein. Cancer Epidemiol, Biomarkers Prev 12: 920-925. (Pubitemid 37151530)
42. Yanagawa N, Tamura G, Honda T, Endoh M, Nishizuka S, Motoyama T. (2004). Demethylation of the synuclein g-gene CpG island in primary gastric cancers and gastric cancer cell lines. Clin Cancer Res 10: 2447-2451. (Pubitemid 38445705)
43. Zhao W, Liu H, Liu W, Wu Y, Chen W, Jiang B et al. (2006). Abnormal activation of the synuclein-gamma gene in hepatocellular carcinomas by epigenetic alteration. Int J Oncology 28: 1081-1088.
44. Zochbauer-Muller S, Fong KM, Virmani AK, Geradts J, Gazdar AF, Minna JD. (2001). Aberrant promoter methylation of multiple genes in non-small cell lung cancers. Cancer Res 61: 249-255. (Pubitemid 32095725)